GlassScriptPhysician profile
Michael J Martin
NPI 1598840217
$3,581.97
in general payments reported to CMS, 2019-2025
19 companies · $827 in 2025
The $827 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $194 · 2021: $401 · 2022: $384 · 2023: $469 · 2024: $690 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,967 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,967.30 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $681.82 | 2022-2025 | Miebo, Xiidra |
| Glaukos Corporation | $560.06 | 2019-2025 | Idosetr |
| Novartis Pharmaceuticals Corporation | $360.92 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $342.25 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $315.85 | 2022-2025 | Tryptyr, Clareon Panoptix Pro, Clareon |
| Sun Pharmaceutical Industries INC. | $274.67 | 2019-2021 | |
| Oyster Point Pharma, INC. | $240.19 | 2023-2024 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $154.64 | 2019 | |
| Kala Pharmaceuticals, INC. | $149.12 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $100.00 | 2019 | |
| Coopervision INC. | $92.04 | 2022 | |
| Rxsight INC | $84.03 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Harrow Eye, LLC | $81.67 | 2024-2025 | Vevye |
| Abbvie INC. | $63.66 | 2022-2024 | |
| Biotissue Holdings INC. | $20.13 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $19.70 | 2024 | Acthar |
| Allergan, INC. | $15.83 | 2021 | |
| Sight Sciences, INC. | $13.98 | 2025 | Omni Surgical System |
| Lensar, INC. | $11.41 | 2024 | Lensar Laser System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.